A person walks past the Pfizer building in New York City, March 2, 2021.
Carlo Allegri | Reuters
Pfizer said Wednesday it is raising the 2021 sales forecast of its Covid-19 vaccine to $33.5 billion from $26 billion, as the delta variant spreads and scientists debate whether people will need booster shots.
In releasing its second-quarter financial results, the company said it sold $7.8 billion in Covid shots in the second quarter. It also reported earnings and revenue that beat Wall Street’s expectations.
Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:
It expects an adjusted pretax profit in the high 20% range of revenue for the vaccine.
This is a developing story. Please check back for updates.
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder…
Senator Elizabeth Warren (D-MA), accompanied by Senator Angus King (I-ME) (L), speaks as General Gregory…
The LA Marathon also congratulated all of the race's podium finishers - including Enyew Nigatwho…
The 10-year Treasury Department The yield initially rose before falling on Monday as oil prices…
The Food and Drug Administration logo is seen before a news conference at Health and…
A few years ago, Grace Guo began to long for places in New York City…
This website uses cookies.